![Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a84262bf2416f30f2c400e67d530b3957f84ba5/2-Table1-1.png)
Table 1 from Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. | Semantic Scholar
![Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002914915019359-gr1.jpg)
Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? - ScienceDirect
![Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score | Journal of the American College of Cardiology Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/2fa1b26c-3e1c-4411-be40-8ccb0a88b743/gr2.jpg)
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score | Journal of the American College of Cardiology
![Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? | Circulation Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? | Circulation](https://www.ahajournals.org/cms/asset/dd179c9e-7f84-4252-81ce-cb52d07ffa45/1498fig02.jpeg)
Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? | Circulation
![Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation - Shields - 2015 - Journal of Internal Medicine - Wiley Online Library Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation - Shields - 2015 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/66cb43a1-6cef-4736-b3cf-44286d0f8616/joim12360-fig-0001-m.jpg)
Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation - Shields - 2015 - Journal of Internal Medicine - Wiley Online Library
![Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions](https://www.ebmedicine.net/media_library/images/MDCalc/CHA2DS2.png)
Atrial Fibrillation: An Approach to Diagnosis and Management in the Emergency Department | Calculated Decisions
![A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram](https://www.researchgate.net/publication/257731952/figure/fig4/AS:669051147796487@1536525632448/A-schematic-representation-showing-the-strategy-of-anticoagulant-use-according-to-CHADS2.png)
A schematic representation showing the strategy of anticoagulant use... | Download Scientific Diagram
Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study | PLOS ONE
![Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis - ScienceDirect Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167527314023778-gr1.jpg)
Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis - ScienceDirect
![Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem? Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?](https://www.escardio.org/static-file/Escardio/Medias/councils/council-for-cardiology-practice/news/Figure%201.%20Decision%20tree%20for%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation.jpg?mts=1592578501000.jpg)
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: how to solve this problem?
![Internal Medicine Board Review: Anticoagulation in atrial fibrillation - CHADS2 vs CHA2DS2-VASc | PPT Internal Medicine Board Review: Anticoagulation in atrial fibrillation - CHADS2 vs CHA2DS2-VASc | PPT](https://image.slidesharecdn.com/anticoagulationinatrialfibrillation-130810201825-phpapp02/85/internal-medicine-board-review-anticoagulation-in-atrial-fibrillation-chads2-vs-cha2ds2vasc-1-320.jpg?cb=1668870082)
Internal Medicine Board Review: Anticoagulation in atrial fibrillation - CHADS2 vs CHA2DS2-VASc | PPT
![Medicina | Free Full-Text | Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study Medicina | Free Full-Text | Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study](https://www.mdpi.com/medicina/medicina-59-01881/article_deploy/html/images/medicina-59-01881-g001.png)
Medicina | Free Full-Text | Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study
![JCM | Free Full-Text | Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction JCM | Free Full-Text | Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction](https://pub.mdpi-res.com/jcm/jcm-11-07090/article_deploy/html/images/jcm-11-07090-g001.png?1669781452)
JCM | Free Full-Text | Association of CHA2DS2-VASc Score with Long-Term Incidence of New-Onset Atrial Fibrillation and Ischemic Stroke after Myocardial Infarction
![Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex) Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)](https://www.tandfonline.com/cms/asset/91626976-4ea2-46bf-913f-7d9870f96617/tacd_a_1720197_f0001_b.jpg)
Full article: Anticoagulation for atrial fibrillation patients with the CHA2DS2-VASc score =1 (beyond sex)
![Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología Does CHA2DS2-VASc Score Select Patients Who Will Benefit Most From Anticoagulation? | Revista Española de Cardiología](https://static.elsevier.es/multimedia/18855857/0000006700000005/v2_201404301330/S1885585714000875/v1_201404301330/en/main.assets/gr1.jpeg)